ATE382340T1 - Lutein/zeaxanthin gegen blendung - Google Patents

Lutein/zeaxanthin gegen blendung

Info

Publication number
ATE382340T1
ATE382340T1 AT03709693T AT03709693T ATE382340T1 AT E382340 T1 ATE382340 T1 AT E382340T1 AT 03709693 T AT03709693 T AT 03709693T AT 03709693 T AT03709693 T AT 03709693T AT E382340 T1 ATE382340 T1 AT E382340T1
Authority
AT
Austria
Prior art keywords
zeaxanthin
lutein
glare
eye tissue
visual performance
Prior art date
Application number
AT03709693T
Other languages
English (en)
Inventor
Felix Barker
Regina Goralczyk
Wolfgang Schalch
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE382340T1 publication Critical patent/ATE382340T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03709693T 2002-01-30 2003-01-23 Lutein/zeaxanthin gegen blendung ATE382340T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02001909 2002-01-30

Publications (1)

Publication Number Publication Date
ATE382340T1 true ATE382340T1 (de) 2008-01-15

Family

ID=27635777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709693T ATE382340T1 (de) 2002-01-30 2003-01-23 Lutein/zeaxanthin gegen blendung

Country Status (8)

Country Link
US (4) US20050032914A1 (de)
EP (1) EP1471898B1 (de)
JP (1) JP2005516049A (de)
CN (1) CN1625395A (de)
AT (1) ATE382340T1 (de)
DE (1) DE60318390T2 (de)
ES (1) ES2299687T3 (de)
WO (1) WO2003063848A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192586B2 (en) * 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
DE20300305U1 (de) * 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Lutein
US20070082066A1 (en) * 2003-05-07 2007-04-12 Gierhart Dennis L Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity
DE20320101U1 (de) 2003-12-23 2004-04-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration
EP1761254B1 (de) * 2004-06-29 2009-09-02 DSMIP Assets B.V. Verbesserung der bildqualität im auge
EP1853239A1 (de) * 2005-02-11 2007-11-14 DSMIP Assets B.V. Verwendung von zeaxanthin zur behandlung von erkrankungen der peripheren retina
JP2009512626A (ja) * 2005-09-08 2009-03-26 ディーエスエム アイピー アセッツ ビー．ブイ． 加齢性黄斑変性症を処置又は予防する方法
EP1920711A1 (de) * 2006-11-13 2008-05-14 DSMIP Assets B.V. Beurteilung und Verbesserung der Sehfähigkeit
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
CN101595977B (zh) 2008-06-02 2013-04-03 浙江医药股份有限公司新昌制药厂 有益于眼睛明视持久度的配方食品及其应用
IT1393710B1 (it) * 2009-04-29 2012-05-08 Graal Srl Composizioni orobuccali contenenti una miscela di luteina e zeaxantina.
ES2602576T3 (es) * 2010-01-16 2017-02-21 Aachener Centrum Für Technologietransfer In Der Ophthalmologie E.V. Composiciones de diol dímero como sustituto de fluidos corporales
JP6026719B2 (ja) * 2010-08-31 2016-11-16 株式会社ダイセル 視機能予防・改善剤
ES2774659T3 (es) 2010-09-24 2020-07-22 Omnivision Gmbh Composición que contiene SOD, luteína y zeaxantina
BR112013024951A2 (pt) * 2011-03-29 2016-12-20 Kemin Ind Inc método de tratamento de tecidos biológicos, membranas ou outras estruturas, e, composição para a coloração de tecidos biológicos, membranas ou outras estruturas
TR201809213T4 (tr) 2011-07-07 2018-07-23 Howard Foundation Holdings Ltd Kamaşma yetersizliğinin iyileştirilmesine yönelik yöntem.
US8697756B2 (en) 2012-07-10 2014-04-15 Acto E.V. Dimer diol compositions as substitutes of body fluids
CN104685428B (zh) 2012-08-28 2017-03-01 戴尔斯生活有限责任公司 用于改善与可居住环境相关联的幸福感的系统、方法以及物件
GB201300055D0 (en) * 2013-01-03 2013-02-20 Howard Foundation Holdings Ltd Identifying subjects in need of treatment
CA2922637A1 (en) * 2013-10-08 2015-04-16 F. Hoffmann-La Roche Ag Use of n-(4-tert-butylbenzyl)-3-chloro-n-[2-(4-chloro-3-ethyl-phenyl)-ethyl]-2-fluoro-5-trifluoromethyl-benzamide for the treatment of eye diseases
CA2924401A1 (en) 2013-12-19 2015-06-25 F. Hoffmann-La Roche Ag Cetp modulator for use in the treatment of eye disease
AU2015223112B2 (en) 2014-02-28 2020-07-09 Delos Living Llc Systems, methods and articles for enhancing wellness associated with habitable environments
US9950008B1 (en) * 2014-08-20 2018-04-24 Marc Bellemore Chewable eye health formulation
CN104397687A (zh) * 2014-11-10 2015-03-11 厦门金达威集团股份有限公司 含多不饱和脂肪酸的营养组合物及其制备方法与应用
EP3265068A4 (de) 2015-03-02 2018-10-31 OmniActive Health Technologies Limited Verfahren zum schutz und zur verbesserung der lebergesundheit mit meso-zeaxanthin-zusammensetzungen
US10532035B2 (en) 2015-03-26 2020-01-14 Omniactive Health Technologies Limited Methods for improvement of visual function and compositions used therein
JP2016185939A (ja) * 2015-03-27 2016-10-27 ロート製薬株式会社 経口組成物
CN104839688A (zh) * 2015-04-20 2015-08-19 华北制药秦皇岛有限公司 一种眼保健制剂及其制备方法
CN105919985A (zh) * 2016-03-23 2016-09-07 李燕铭 一种具有抗氧化、延缓衰老、预防老年性黄斑病变的医药保健品
KR101820944B1 (ko) 2016-06-17 2018-01-22 주식회사 이노벳 반려동물 안과질환 관리 보조영양제와 그 제조방법
US11338107B2 (en) 2016-08-24 2022-05-24 Delos Living Llc Systems, methods and articles for enhancing wellness associated with habitable environments
US10620645B2 (en) * 2017-08-03 2020-04-14 Trane International Inc. Microzone HVAC system with precision air device
EP3655018A2 (de) * 2017-08-21 2020-05-27 Lonza LLC Zusammensetzung und daraus hergestelltes nahrungsergänzungsmittel
WO2019046580A1 (en) 2017-08-30 2019-03-07 Delos Living Llc SYSTEMS, METHODS AND ARTICLES FOR EVALUATING AND / OR IMPROVING HEALTH AND WELL-BEING
DE102017009186A1 (de) 2017-09-25 2019-03-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Lutein und -derivate enthaltende Zusammensetzung sowie Verfahren zur Herstellung
CN109112150B (zh) * 2017-12-11 2021-02-23 华中农业大学 OsLUT2基因在水稻光保护中的应用
US11649977B2 (en) 2018-09-14 2023-05-16 Delos Living Llc Systems and methods for air remediation
US11141386B1 (en) 2018-12-28 2021-10-12 QH Holdings (Oregon), Inc. Eye health supplement with curcumin
US11135179B1 (en) 2018-12-28 2021-10-05 QH Holdings (Oregon), Inc. Eye health supplement
WO2020176503A1 (en) 2019-02-26 2020-09-03 Delos Living Llc Method and apparatus for lighting in an office environment
US11898898B2 (en) 2019-03-25 2024-02-13 Delos Living Llc Systems and methods for acoustic monitoring
KR20220082812A (ko) * 2019-10-15 2022-06-17 옴니액티브 헬스 테크놀로지스 리미티드 루테인 및 제아잔틴을 포함하는 생체이용가능성이 증강된 크산토필 조성물
DE102020115238A1 (de) * 2020-06-09 2021-12-09 Pm-International Ag Nahrungsergänzungsmittel und Nahrungsmittel
CN112426414B (zh) * 2020-12-03 2022-02-08 温州医科大学 一种眼部抗黏连和防蓝光损伤的护理液及其制备方法
ES2886723A1 (es) 2021-07-23 2021-12-20 Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunidad Valenciana Fisabio Composicion basada en la actividad antioxidante de la enzima superoxido dismutasa y su aplicacion en enfermedades oculares
US20230190672A1 (en) * 2021-12-21 2023-06-22 Sophia Holdings, S.A. De C.V. Pharmaceutical ophthalmic compositions for protection against blue light
EP4432857A1 (de) * 2022-04-01 2024-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH Zusammensetzung zum schutz des auges
KR20240034947A (ko) 2022-09-07 2024-03-15 전북대학교산학협력단 크립토캅신과 루테인을 주성분으로 하는 복합 추출물 및 그의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048203A (en) * 1976-12-06 1977-09-13 Thomas Philip Purification of lutein-fatty acid esters from plant materials
CA2224217C (en) * 1995-06-07 2010-04-13 The Howard Foundation Pharmaceutically active carotenoids
US5955102A (en) * 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
AU2002258077B2 (en) * 2001-02-23 2007-03-15 Richard H. Binnington Novel carotenoid esters
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US6743953B2 (en) * 2002-08-26 2004-06-01 Kancor Flavours & Extracts Ltd. Process for the preparation of xanthophyll crystals
EP1563081A4 (de) * 2002-10-25 2005-10-26 Verfahren zur herstellung von verestertem astaxanthin aus verestertem zeaxanthin
JP4260113B2 (ja) * 2002-12-18 2009-04-30 コリアナ・コスメティック・カンパニー・リミテッド 新規なレチノール誘導体及びそれを含む化粧料組成物

Also Published As

Publication number Publication date
EP1471898B1 (de) 2008-01-02
ES2299687T3 (es) 2008-06-01
DE60318390D1 (de) 2008-02-14
US20120003198A1 (en) 2012-01-05
JP2005516049A (ja) 2005-06-02
CN1625395A (zh) 2005-06-08
WO2003063848A1 (en) 2003-08-07
US20130296442A1 (en) 2013-11-07
US20050032914A1 (en) 2005-02-10
US20150018428A1 (en) 2015-01-15
DE60318390T2 (de) 2008-12-18
EP1471898A1 (de) 2004-11-03

Similar Documents

Publication Publication Date Title
ATE382340T1 (de) Lutein/zeaxanthin gegen blendung
CA184602S (en) Display screen with graphical user interface
AR059102A1 (es) Composiciones que comprenden extracto de ciruela kakadu o extracto de frutos de asai
CA171186S (en) Display screen with animated graphical user interface
CA171187S (en) Display screen with animated graphical user interface
CR10307A (es) Anteojos con caracteristicas de union a una mascarilla
WO2008004206A3 (en) Carotenoid compositions useful for whitening skin
CA171189S (en) Display screen with animated graphical user interface
DE60203522D1 (de) Neuartige, stabilisierte carotenoid-mischungen
EA200870177A1 (ru) Новый гликозилированный вариант fsh d3n
CN104083031A (zh) 一种单面镜相框
EP4216822A4 (de) P-adisches eeg-quantenpotential bei neuropsychiatrischen erkrankungen
CN205261448U (zh) 一种遮光罩
CN204790766U (zh) 一种发光机箱
CN105241313A (zh) 一种单兵盾牌
CN205193308U (zh) 一种2.5D ogs-3D高清防蓝光膜
DE602004031216D1 (de) Bleichaktive geruchsbindende chlorbleichzusammensetzung
TWD191835S (zh) Glasses (22)
CN201319095Y (zh) 耳塞眼镜
CN205118747U (zh) 一种新型曲线灯
CN111294418A (zh) 带镜子的手机壳
Santana et al. Low States of Polars from CRTS Optical Light Curves
CN204739468U (zh) 一种机械式多功能台灯
CN204028502U (zh) 一种带剪刀的眼镜
CN105444113A (zh) 一种遮光罩

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties